This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 2000;283:48-50.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 1999;48:961-967

2 figures, 2 tables omitted

Vaccination is an important public health intervention for reducing morbidity and mortality from influenza and pneumonia among persons with diabetes.^1-2 A national health objective for 2000 is to increase influenza and pneumococcal vaccination rates to 60% among persons at high risk for complications from influenza and pneumonia, including persons with diabetes (objective 20.11).³ Although the Advisory Committee on Immunization Practices (ACIP) recommends that all persons with diabetes be vaccinated, data from the 1993 Behavioral Risk Factor Surveillance System (BRFSS) showed that 40% of persons with diabetes reported receiving an influenza vaccination within the previous year, and 21% reported ever receiving a pneumococcal vaccination.⁴ To assess the vaccination rates among persons with diabetes in 52 reporting areas (i.e., 50 states, the District of Columbia, and Puerto Rico), CDC and the Council of State and Territorial Epidemiologists (CSTE) analyzed data from the 1997 BRFSS. This . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?